Trial intelligence / Profile preview

Bioequivalence of Camoquin Suspension vs Flavoquine Tablets

NCT00859807Phase 4Completed

Sponsor
Pfizer
Start
May 2009
Primary completion
Jun 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of amodiaquine in Malaria, sponsored by Pfizer. Started May 2009; status: completed.

02

Drugs

amodiaquine
03

Conditions

Malaria

Beyond the preview

Go deeper on NCT00859807.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00859807.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call